Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityActive in the last 2 years

Jiantao Mo

Matched on OpenAlex author ID A5082747663. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2022: 3 papers · 2023: none · 2024: 1 paper · 2025: 3 papers · 2026: 1 paper

Papers 8

  1. Nanomagnetic Hyperthermia Sensitizes Gemcitabine Chemosensitivity in Pancreatic Cancer by Inhibiting HSPB1 to Amplify ACSL4-Mediated Ferroptosis. Co-author DOI 10.1002/smll.202514973↗
  2. NEAT1 promotes the perineural invasion of pancreatic cancer via the E2F1/GDNF axis. Co-author DOI 10.1016/j.canlet.2025.217497↗
  3. Chlorophyllin exerts synergistic anti-tumor effect with gemcitabine in pancreatic cancer by inducing cuproptosis. Co-author DOI 10.1186/s10020-025-01180-y↗
  4. Tobacco carcinogen NNK promotes pancreatic cancer proliferation via LINC00857/β-catenin. Co-author DOI 10.18332/tid/203455↗
  5. Pharmacological inhibition of SREBP1 suppresses pancreatic cancer growth via inducing GPX4-mediated ferroptosis. Co-author DOI 10.1016/j.cellsig.2024.111381↗
  6. Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3/GPX4 signalling. Co-author DOI 10.1038/s41419-022-05082-3↗
  7. Correction: Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3/GPX4 signalling. Co-author DOI 10.1038/s41419-022-05236-3↗
  8. Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma. Co-author DOI 10.3389/fgene.2022.940794↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qingyong Ma · 6 shared papers, 2022–2025 · strength 1.11
  2. Zheng Wu · 5 shared papers, 2022–2026 · strength 1.02
  3. Weikun Qian · 5 shared papers, 2022–2025 · strength 0.90
  4. Zheng Wang · 5 shared papers, 2022–2025 · strength 0.87
  5. Cancan Zhou · 3 shared papers, 2022–2025 · strength 0.58
  6. Jiaqiang Ren · 2 shared papers, 2025–2026 · strength 0.52
  7. Liang Han · 2 shared papers, 2025 · strength 0.49
  8. Ruiqi Cao · 2 shared papers, 2024–2025 · strength 0.44
  9. Weifan Zhang · 3 shared papers, 2022 · strength 0.43
  10. Simei Zhang · 2 shared papers, 2022 · strength 0.28
  11. Zeen Zhu · 2 shared papers, 2022 · strength 0.28
  12. Wunai Zhang · 2 shared papers, 2022 · strength 0.28
  13. Bo Zhang · 2 shared papers, 2022 · strength 0.28
  14. Shuai Wu · 1 shared paper, 2025 · strength 0.25
  15. Tao Qin · 1 shared paper, 2025 · strength 0.25
  16. Zheng Wang · 1 shared paper, 2025 · strength 0.25
  17. Jingtao Gu · 1 shared paper, 2025 · strength 0.25
  18. Jiguang Ma · 1 shared paper, 2025 · strength 0.25
  19. Wanxing Duan · 1 shared paper, 2025 · strength 0.25
  20. Jie Hao · 1 shared paper, 2025 · strength 0.23
  21. Wei Li · 1 shared paper, 2024 · strength 0.21
  22. Zheng Wu · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.